Open AccessDoxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma
Author(s) -
Mohammad Arabi,
Ali Benmousa,
Khaled Bzeizi,
Fares Garad,
Ishtiaq Ahmed,
Melfi Al-Otaibi
Publication year - 2015
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.157571
Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , doxorubicin , adverse effect , progressive disease , toxicity , response evaluation criteria in solid tumors , surgery , chemotherapy
To compare the efficacy and safety profile of doxorubicin-loaded drug-eluting beads (DEB) to the conventional TACE (C-TACE) in the management of nonresectable hepatocellular carcinoma (HCC).